Alicia Martín Roldán

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Alicia Martín Roldán, María Del Mar Sánchez Suárez, Carolina Alarcón-Payer, Alberto Jiménez Morales, José Manuel Puerta Puerta
A Real-World Evidence-Based Study of Long-Term Tyrosine Kinase Inhibitors Dose Reduction or Discontinuation in Patients with Chronic Myeloid Leukaemia. Pharmaceutics 15 (5) (2023)
María Del Mar Sánchez Suárez, Alicia Martín Roldán, Carolina Alarcón-Payer, Miguel Ángel Rodríguez-Gil, Jaime Eduardo Poquet-Jornet, Jose Manuel Puerta-Puerta, Alberto Jiménez Morales
Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era. Pharmaceutics 16 (1) (2023)
María Del Mar Sánchez Suárez, Alicia Martín Roldán, Carolina Alarcón-Payer, Miguel Ángel Rodríguez-Gil, Jaime Eduardo Poquet-Jornet, Jose Manuel Puerta-Puerta, Alberto Jiménez Morales
Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era. Pharmaceutics 16 (1) (2023)
María Del Mar Sánchez Suárez, Alicia Martín Roldán, Carolina Alarcón-Payer, Miguel Ángel Rodríguez-Gil, Jaime Eduardo Poquet-Jornet, Jose Manuel Puerta-Puerta, Alberto Jiménez Morales
Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era. Pharmaceutics 16 (1) (2023)